12th International Congress on Myeloproliferative Neoplasms

 

12th International Congress on Myeloproliferative Neoplasms
J

66 y/o Female w/ Systemic Mastocytosis Associated with CEL: Clinical Efficacy of KIT Inhibitors, Potential Role of HSCT

By 12th International Congress on Myeloproliferative Neoplasms FEATURING Jason R. Gotlib
By 12th International Congress on Myeloproliferative Neoplasms FEATURING Jason R. Gotlib
15 views
November 25, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
Cases
06:02

66 y/o Female w/ Aggressive Systemic Mastocytosis: AHNs Are Under-Di…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

20 views
02:58

73 y/o Male w/ Aggressive Systemic Mastocytosis: High-Sensitive Assa…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

12 views
03:11

73 y/o Male w/ SM-AHM: Work Through Whether SM or AHN Is the Major C…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

14 views
04:59

68 y/o Female w/ Systemic Mastocytosis with Chronic Myelomonocytic L…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

20 views
02:43

28 y/o Female w/ Well-Differentiated Systemic Mastocytosis: Imatinib…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

15 views
07:53

66 y/o Female w/ Systemic Mastocytosis Associated with CEL: Clinical…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

15 views